Literature DB >> 26170185

Changing Epidemiology of Mucoralean Fungi: Chronic Cutaneous Infection Caused by Mucor irregularis.

Jagdish Chander1, Mandeep Kaur, Mala Bhalla, Rajpal Singh Punia, Nidhi Singla, Kalyani Bhola, Ana Alastruey-Izquierdo, Alberto M Stchigel, Josep Guarro.   

Abstract

INTRODUCTION: The fungi pertaining to order Mucorales usually cause an acute form of clinical disease called mucormycosis. A primary chronic presentation in an immunocompetent patient is a rare form of mucormycosis. Mucor irregularis is known for causing chronic cutaneous infections geographically confined to Asia, mainly in China. We describe a case of primary chronic cutaneous mucormycosis caused by M. irregularis from a new geographical niche in India, highlighting changing aspects of its epidemiology. CASE
PRESENTATION: The patient was a farmer with a history of skin lesions over the lower limb for the past 6 years. The biopsy taken from the lesions showed pauci-septate hyphae with right-angle branching on KOH wet mount as well as special fungal stains. On fungal culture, greyish-white cottony mycelial growth of Mucormycetes was obtained. The strain was finally identified as M. irregularis on macro- and microscopic features on 2 % MEA and DNA sequencing. The antifungal susceptibility was done using EUCAST broth microdilution method and was found to be susceptible to commonly used antifungal agents. The patient was started on oral itraconazole and saturated solution of potassium iodide (SSKI). While undergoing treatment for 2 months, he was lost to follow-up, however, after a year when he recently visited the hospital; the disease got completely healed with no new crops of skin lesions.
CONCLUSION: Mucoralean fungi should also be suspected in cases with chronic presentation, in immunocompetent host, as there is emergence of such fungi in new endemic areas, particularly located in Asia. The role of other antifungal agents apart from amphotericin B for the treatment of chronic mucormycosis needs to be explored.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26170185     DOI: 10.1007/s11046-015-9908-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

1.  Rhizomucor variabilis: a rare causative agent of primary cutaneous zygomycosis.

Authors:  A B Patil; K Chandramohan; M R Shivaprakash; S D Nadgir; S A Lakshminarayana
Journal:  Indian J Med Microbiol       Date:  2013 Jul-Sep       Impact factor: 0.985

2.  Primary cutaneous mucormycosis caused by Mucor irregularis in an immunocompetent patient.

Authors:  Yoshihiro Matsudate; Kazutoshi Murao; Yoshio Urano; Kyoko Yarita; Katsuhiko Kamei; Hiromi Takeichi; Yoshiaki Kubo
Journal:  J Dermatol       Date:  2015-03       Impact factor: 4.005

3.  Lethal invasive mucormycosis: case report and recommendations for treatment.

Authors:  N F Ribeiro; G C Cousin; G E Wilson; D M Butterworth; R T Woodwards
Journal:  Int J Oral Maxillofac Surg       Date:  2001-04       Impact factor: 2.789

4.  Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India.

Authors:  B M Hemashettar; R N Patil; Kerry O'Donnell; Vishnu Chaturvedi; Ping Ren; Arvind A Padhye
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

5.  Two new species of Mucor from clinical samples.

Authors:  Eduardo Alvarez; Josep Cano; Alberto M Stchigel; Deanna A Sutton; Annette W Fothergill; Valentina Salas; Michael G Rinaldi; Josep Guarro
Journal:  Med Mycol       Date:  2010-07-22       Impact factor: 4.076

6.  Slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman.

Authors:  Zhi-Kuan Xia; Wen-Ling Wang; Rong-Ya Yang
Journal:  Clin Infect Dis       Date:  2012-12-14       Impact factor: 9.079

Review 7.  Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature.

Authors:  Dong Ming Li; Li De Lun
Journal:  Mycopathologia       Date:  2012-06-29       Impact factor: 2.574

8.  Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia.

Authors:  Mayssa M Abuali; Roberto Posada; Gustavo Del Toro; Elizabeth Roman; Rama Ramani; Sudha Chaturvedi; Vishnu Chaturvedi; Vincent J LaBombardi
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

Review 9.  Use of potassium iodide in dermatology: updates on an old drug.

Authors:  Rosane Orofino Costa; Priscila Marques de Macedo; Aline Carvalhal; Andréa Reis Bernardes-Engemann
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

10.  Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosis.

Authors:  X-L Lu; M J Najafzadeh; S Dolatabadi; Y-P Ran; A H G Gerrits van den Ende; Y-N Shen; C-Y Li; L-Y Xi; F Hao; Q-Q Zhang; R-Y Li; Z-M Hu; G-X Lu; J-J Wang; M Drogari-Apiranthitou; C Klaassen; J F Meis; F Hagen; W-D Liu; G S de Hoog
Journal:  Persoonia       Date:  2013-03-06       Impact factor: 11.051

View more
  6 in total

1.  Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.

Authors:  Yu-Hong Li; Peng Sun; Jian-Chao Guo
Journal:  Mycopathologia       Date:  2017-06-30       Impact factor: 2.574

2.  Disfiguring Mucor irregularis Infection Cured by Amphotericin B and Itraconazole: A Case Report and Treatment Experience.

Authors:  Lin-Wei Wei; Hong Wang; Ying-Gai Song; Jin Yu
Journal:  Mycopathologia       Date:  2019-09-17       Impact factor: 2.574

3.  In Vivo and In Vitro Impairments in T Helper Cell and Neutrophil Responses against Mucor irregularis in Card9 Knockout Mice.

Authors:  Lingyue Sun; Shuzhen Zhang; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

4.  Role of COVID 19 Inflammatory Markers in Rhino-Orbito-Cerebral Mucormycosis: A Case Study in Predisposed Patients at a Designated Nodal Centre.

Authors:  Nitya Goddanti; Y Mounika Reddy; M Kiran Kumar; M Rajesh; L Sudarshan Reddy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-11-13

5.  Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India.

Authors:  Jagdish Chander; Mandeep Kaur; Nidhi Singla; R P S Punia; Surinder K Singhal; Ashok K Attri; Ana Alastruey-Izquierdo; Alberto M Stchigel; Jose F Cano-Lira; Josep Guarro
Journal:  J Fungi (Basel)       Date:  2018-04-06

6.  Heterotrimeric G-alpha subunits Gpa11 and Gpa12 define a transduction pathway that control spore size and virulence in Mucor circinelloides.

Authors:  J Alberto Patiño-Medina; Nancy Y Reyes-Mares; Marco I Valle-Maldonado; Irvin E Jácome-Galarza; Carlos Pérez-Arques; Rosa E Nuñez-Anita; Jesús Campos-García; Verónica Anaya-Martínez; Rafael Ortiz-Alvarado; Martha I Ramírez-Díaz; Soo Chan Lee; Victoriano Garre; Víctor Meza-Carmen
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.